181 related articles for article (PubMed ID: 3161165)
1. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
[TBL] [Abstract][Full Text] [Related]
2. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
Kuhl DE; Metter EJ; Riege WH
Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolism of glucose in benign hereditary chorea.
Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
[TBL] [Abstract][Full Text] [Related]
4. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
Kuhl DE; Metter EJ; Riege WH; Markham CH
Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
[TBL] [Abstract][Full Text] [Related]
5. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
[TBL] [Abstract][Full Text] [Related]
6. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
[TBL] [Abstract][Full Text] [Related]
7. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
[TBL] [Abstract][Full Text] [Related]
8. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
[TBL] [Abstract][Full Text] [Related]
9. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
10. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Okada J; Peppard R; Calne DB
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
[TBL] [Abstract][Full Text] [Related]
11. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
12. Normal caudate glucose metabolism in persons at risk for Huntington's disease.
Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R
Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844
[TBL] [Abstract][Full Text] [Related]
13. Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
Foster NL; Chase TN; Patronas NJ; Gillespie MM; Fedio P
Ann Neurol; 1986 Feb; 19(2):139-43. PubMed ID: 3485952
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in the early diagnosis of Huntington's disease.
Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
[TBL] [Abstract][Full Text] [Related]
15. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
[TBL] [Abstract][Full Text] [Related]
16. Cerebral glucose metabolism in the Lennox-Gastaut syndrome.
Theodore WH; Rose D; Patronas N; Sato S; Holmes M; Bairamian D; Porter RJ; Di Chiro G; Larson S; Fishbein D
Ann Neurol; 1987 Jan; 21(1):14-21. PubMed ID: 3103526
[TBL] [Abstract][Full Text] [Related]
17. Imaging local brain function with emission computed tomography.
Kuhl DE
Radiology; 1984 Mar; 150(3):625-31. PubMed ID: 6607481
[TBL] [Abstract][Full Text] [Related]
18. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
Leenders KL; Frackowiak RS; Quinn N; Marsden CD
Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559
[TBL] [Abstract][Full Text] [Related]
19. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
20. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]